These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 7874191

  • 21. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS.
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR, Gadducci A, Gambacciani M.
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [Abstract] [Full Text] [Related]

  • 24. Links between hormone replacement therapy and neoplasia.
    Hulka BS.
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A.
    Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
    [Abstract] [Full Text] [Related]

  • 28. Progesterone and endometrial cancer.
    Gompel A.
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
    [Abstract] [Full Text] [Related]

  • 29. Use of HRT and the subsequent risk of cancer.
    Beral V, Banks E, Reeves G, Appleby P.
    J Epidemiol Biostat; 1999 Nov; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [Abstract] [Full Text] [Related]

  • 30. Endometrial safety and bleeding with HRT: what's new?
    Sturdee DW.
    Climacteric; 2007 Oct; 10 Suppl 2():66-70. PubMed ID: 17882676
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The role of hormones in the etiology and prevention of endometrial cancer.
    Gambrell RD.
    Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
    Gibbons WE, Thorneycroft IH.
    J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
    [Abstract] [Full Text] [Related]

  • 38. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Cline JM.
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Hormone substitution therapy in menopause and risk of breast cancer].
    Colin C.
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):27-8. PubMed ID: 2068481
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.